+ − Summary
+ − Full Texts (3)
+ − Actions (67)
- Governor Approved
- Effective Date June 10, 2022
- Public Act . . . . . . . . . 102-1055
- Sent to the Governor
- Motion to Reconsider Vote - Withdrawn Rep. Daniel Didech
- Passed Both Houses
- Senate Committee Amendment No. 1 House Concurs 095-014-000
- Senate Committee Amendment No. 2 House Concurs 095-014-000
- Senate Floor Amendment No. 3 House Concurs 095-014-000
- House Concurs
- Motion Filed to Reconsider Vote Rep. Daniel Didech
- Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
- Senate Committee Amendment No. 2 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
- Senate Floor Amendment No. 3 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
- Senate Committee Amendment No. 1 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
- Senate Committee Amendment No. 2 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
- Senate Floor Amendment No. 3 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
- Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee
- Senate Committee Amendment No. 2 Motion to Concur Referred to Rules Committee
- Senate Floor Amendment No. 3 Motion to Concur Referred to Rules Committee
- Arrived in House
- Placed on Calendar Order of Concurrence Senate Amendment(s) 1, 2, 3
- Recalled to Second Reading
- Senate Floor Amendment No. 3 Adopted; Fine
- Placed on Calendar Order of 3rd Reading
- Third Reading - Passed; 046-002-000
- Senate Floor Amendment No. 3 Recommend Do Adopt Executive; 015-000-000
- Senate Floor Amendment No. 3 Assignments Refers to Executive
- Senate Floor Amendment No. 3 Filed with Secretary by Sen. Laura Fine
- Senate Floor Amendment No. 3 Referred to Assignments
- Senate Committee Amendment No. 1 Adopted
- Senate Committee Amendment No. 2 Adopted
- Do Pass as Amended Executive; 016-000-000
- Placed on Calendar Order of 2nd Reading
- Second Reading
- Placed on Calendar Order of 3rd Reading March 24, 2022
- Senate Committee Amendment No. 1 Assignments Refers to Executive
- Senate Committee Amendment No. 2 Assignments Refers to Executive
- Senate Committee Amendment No. 2 Filed with Secretary by Sen. Laura Fine
- Senate Committee Amendment No. 2 Referred to Assignments
- Senate Committee Amendment No. 1 Filed with Secretary by Sen. Laura Fine
- Senate Committee Amendment No. 1 Referred to Assignments
- Assigned to Executive
- Arrive in Senate
- Placed on Calendar Order of First Reading
- Chief Senate Sponsor Sen. Laura Fine
- First Reading
- Referred to Assignments
- Third Reading - Short Debate - Passed 096-013-000
- Second Reading - Short Debate
- House Floor Amendment No. 2 Adopted
- Placed on Calendar Order of 3rd Reading - Short Debate
- House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 004-000-000
- House Floor Amendment No. 2 Filed with Clerk by Rep. Jennifer Gong-Gershowitz
- House Floor Amendment No. 2 Referred to Rules Committee
- Placed on Calendar 2nd Reading - Short Debate
- House Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote
- Do Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 015-002-000
- House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
- House Committee Amendment No. 1 Filed with Clerk by Rep. Jennifer Gong-Gershowitz
- House Committee Amendment No. 1 Referred to Rules Committee
- Assigned to Prescription Drug Affordability & Accessibility Committee
- Rule 19(a) / Re-referred to Rules Committee
- Assigned to Prescription Drug Affordability & Accessibility Committee
- First Reading
- Referred to Rules Committee
- Filed with the Clerk by Rep. Jennifer Gong-Gershowitz
+ − Adopted Amendments (5)
Senate Amendment 003
Requires the Environmental Protection Agency to provide a 30-day public comment period on drug take-back program proposals and revised proposals during specified 90-day periods. Provides that the reason for the Agency's rejection of a drug take-back program proposal must be provided in the written notification to the manufacturer program operator.
Senate Amendment 002
Removes language providing that the definition of "covered manufacturer" does not include a pharmacy. Provides that private label distributors and repackagers are not covered manufacturers.
Senate Amendment 001
In provisions of the Drug Take-Back Act, makes the following changes. Provides that "covered drug" does not include drugs sold at retail as a unit dose package or homeopathic drugs. Makes changes to the definition of "proprietary information". Provides that program promotion requirements do not apply to any drug take-back program established prior to the Act's effective date that provides promotional or educational materials to the public about the proper collection and management of covered drugs. Provides that each covered manufacturer and covered manufacturer program operator shall submit a registration fee of $2,500 (rather than $5,000).
House Amendment 002
Provides that "covered drug" means, among other things, a drug. Makes a typographical change.
House Amendment 001
Replaces everything after the enacting clause with the provisions of the introduced bill with the following changes. Provides that each covered manufacturer must, beginning January 1, 2024 (rather than no later than July 1, 2022) or 6 months after becoming a covered manufacturer, individually or collectively implement (rather than participate in) an approved drug take-back program. Requires a drug take-back program to provide for the collection, transportation, and disposal of covered drugs. Provides that specified requirements shall be undertaken by a drug take-back program or a covered manufacturer (rather than a manufacturer program operator). Requires the Environmental Protection Agency to review all proposals in conjunction with one another to ensure the proposals are coordinated to achieve authorized collection site coverage. Requires the Agency to either approve, reject, or approve with modification a proposal within 90 days after receiving it. Requires drug take-back program promotion to be implemented by all drug take-back programs collectively. Provides that a manufacturer program operator shall (rather than may) allocate administration and operation costs of programs to participating covered manufacturers. Requires each covered manufacturer and manufacturer program operator to register with the Agency and submit the registration fee by January 1, 2023 (rather than April 1, 2022), and by January 1 (rather than April 1) of each year thereafter. Removes language requiring penalties collected under the Act to be used in accordance with the Act's provisions. Removes language allowing the Agency to impose a civil penalty for a violation of the Act of $7,000 per violation per day. Makes other changes. Amends the Environmental Protection Act. Provides that moneys in the Solid Waste Management Fund shall be used for the administration of the Drug Take-Back Act. Removes provisions requiring the Agency to (1) develop and implement a public information program regarding household waste drop-off points that accept pharmaceutical products, as well as mail-back programs; (2) develop a sign that provides information on the proper disposal of unused pharmaceutical products; and (3) establish, by rule, a statewide medication take-back program by June 1, 2016 to ensure that there are pharmaceutical product disposal options regularly available for residents across the State. Makes other changes. Effective immediately.
+ − Proposed Amendments (5)
+ − Statutes Amended (4)
- New Act
- 5 ILCS 140/7 - from Ch. 116, par. 207
- 415 ILCS 5/22.15 - from Ch. 111 1/2, par. 1022.15
- 415 ILCS 5/22.55